Bg pattern

RAVICTI 1.1 G/ML ORAL LIQUID

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RAVICTI 1.1 G/ML ORAL LIQUID

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information: Summary of Product Characteristics

Ravicti1,1g/ml oral liquid

glycerol phenylbutyrate

Read this entire summary of product characteristics carefully before you start taking this medicine, as it contains important information for you.

  • Keep this summary of product characteristics, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this summary of product characteristics. See section 4.

Contents of the Summary of Product Characteristics

  1. What is Ravicti and what is it used for
  2. What you need to know before you take Ravicti
  3. How to take Ravicti
  4. Possible side effects
  5. Storage of Ravicti
  6. Package contents and further information

1. What is RAVICTI and what is it used for

Ravicti contains the active substance glycerol phenylbutyrate, which is used to treat six known urea cycle disorders (UCDs) in adults, adolescents, and children. UCDs include deficiencies of certain liver enzymes, such as carbamoyl phosphate synthetase I (CPS), ornithine transcarbamylase (OTC), argininosuccinate synthetase (ASS), argininosuccinate lyase (ASL), arginase I (ARG), and hyperammonemia-hyperornithinemia-homocitrullinuria syndrome (HHH).

RAVICTI should be combined with a low-protein diet and, in some cases, with a diet supplemented with essential amino acids (such as arginine, citrulline, and non-protein calorie supplements).

About Urea Cycle Disorders

  • In urea cycle disorders, the body cannot remove nitrogen from the proteins we consume.
  • Normally, the body converts excess nitrogen from proteins into a waste product called ammonia. The liver then removes ammonia from the body through a cycle called the urea cycle.
  • In urea cycle disorders, the body is unable to produce sufficient liver enzymes to remove excess nitrogen.
  • As a result, ammonia accumulates in the body. If ammonia is not removed from the body, it can damage the brain and cause partial loss of consciousness or coma.
  • Urea cycle disorders are rare.

How RAVICTI works

Ravicti helps the body remove waste nitrogen. This reduces the amount of ammonia in the body.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take RAVICTI

Do not takeRavicti

  • if you are allergic to glycerol phenylbutyrate.
  • if you have hyperammonemia (high levels of ammonia in the blood) that requires more rapid intervention (see the section "Warnings and precautions").

If you are unsure whether you are in any of the above situations, consult your doctor or pharmacist before taking Ravicti.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Ravicti:

  • if you have liver or kidney problems, as RAVICTI is eliminated from the body through these organs.
  • if you have pancreas, stomach, or intestine problems, as these organs are responsible for the absorption of RAVICTI in the body.

If you are in any of the above situations, consult your doctor or pharmacist before taking Ravicti.

In some cases, such as infection or post-operative, the amount of ammonia may increase despite treatment with glycerol phenylbutyrate and may damage the brain (hyperammonemic encephalopathy).

In other cases, the amount of ammonia in the blood may increase rapidly. In this case, RAVICTI will not cause the amount of ammonia in the blood to increase to excessively high levels.

High levels of ammonia in the blood cause nausea, vomiting, or a feeling of confusion.

Tell your doctor or go to the hospital immediately if you notice any of these signs.

It will be necessary to perform blood tests so that your doctor can determine and maintain the correct dose for you.

Other medicines and RAVICTI

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines, which may be less effective when used with RAVICTI. If you are taking these medicines, you may need to have regular blood tests:

  • midazolam and barbiturates (used for sedation, sleep problems, or epilepsy)
  • contraceptives

Also, tell your doctor if you are taking any of the following medicines, as they may increase the amount of ammonia in the body or change the way RAVICTI works:

  • corticosteroids (used to treat inflamed areas of the body)
  • valproic acid (a medicine for epilepsy)
  • haloperidol (used to treat some mental health problems)
  • probenecid (for treating high levels of uric acid in the blood, which can cause gout ["hyperuricemia"])
  • lipase inhibitors (such as orlistat): used to treat obesity
  • lipase in pancreatic enzyme replacement treatments.

If you are in any of the above situations (or are unsure), consult your doctor before taking Ravicti.

Pregnancy, contraception, and breastfeeding

  • If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using Ravicti. If you become pregnant during treatment with Ravicti, consult your doctor. RAVICTI should not be used during pregnancy, as the risks to the fetus cannot be ruled out.
  • If you are a woman who can become pregnant, you must use an effective contraceptive method during treatment with Ravicti. Consult your doctor about which contraceptive method is best for you.
  • If you plan to breastfeed while taking RAVICTI, you should talk to your doctor. It will be necessary to decide whether to stop breastfeeding or stop treatment, considering the benefit of breastfeeding for the child and the benefit of treatment for you, as RAVICTI may pass into breast milk and the risk to newborns/children cannot be excluded.

Driving and using machines

Ravicti's influence on the ability to drive and use machines is important. When you take RAVICTI, you may feel dizzy or have a headache. Do not drive or use machines while you are experiencing these side effects.

3. How to take RAVICTI

Follow the instructions for administering this medicine exactly as indicated by your doctor. If you are unsure, consult your doctor or pharmacist again.

You must follow a special low-protein diet during treatment with RAVICTI.

  • This diet will be designed for you by your doctor and dietitian.
  • You must follow it carefully.
  • You may need to take amino acid supplements.
  • You will need to receive treatment and follow a diet for the rest of your life, unless you have a successful liver transplant.

Amount to be taken

Your doctor will tell you how much Ravicti to take each day.

  • Your daily dose will depend on your size and weight, the amount of protein in your diet, and the overall condition of the urea cycle disorder.
  • Your doctor may give you a lower dose if you have kidney or liver problems.
  • You will need regular blood tests so that your doctor can determine the correct dose for you.
  • Your doctor may tell you to take Ravicti more than 3 times a day. In young children, it may be 4 to 6 times a day. There should be at least 3 hours between each dose.

Taking this medicine

Your doctor will tell you how to take Ravicti oral liquid. It can be taken in the following ways:

  • by mouth
  • through a tube that goes from the abdomen to the stomach, called a "gastrostomy tube"
  • through a tube that goes from the nose to the stomach, called a "nasogastric tube".

Take RAVICTI by mouth unless your doctor tells you otherwise.

Ravicti and meals

Take Ravicti during or just after a meal. Young children should receive the medicine during or just after feeding.

Dose measurement

  • Use an oral syringe to measure your dose.
  • You must have the RAVICTI bottle with an oral syringe to administer the correct amount of RAVICTI.
  1. Open the RAVICTI bottle by pressing the cap and turning it to the left.
  2. Hand turning the needle adapter on the medicine vial with arrows indicating the direction of rotation
  3. Place the end of the oral syringe into the syringe insert integrated into the bottle.

Hand holding vial with liquid and connecting transparent syringe with needle to its top

  1. Hold the bottle upside down while keeping the oral syringe inserted.

Hand holding a device with two connected cylinders and a curved arrow indicating rotation

  1. Fill the oral syringe by pulling the plunger back until the syringe is filled with the amount of RAVICTI liquid that your doctor has told you to take.
    1. Note: If possible, use the oral syringe size in milliliters that is closest to the recommended dose, without being less than this dose (for example, if the dose is 0.8 ml, use a 1 ml oral syringe).

Hand holding a pre-filled injection device with a transparent needle protector and a lower push button

  1. Tap the oral syringe to remove air bubbles, making sure you have filled it with the correct amount of liquid.

Two pharmaceutical vials, one with a prohibition cross and the other with a visible liquid level and measurement marks

  1. Swallow the liquid from the oral syringe or connect the oral syringe to a gastrostomy tube or nasogastric tube.

Hand holding an inhaler with a mouthpiece inserted into the patient's mouth to administer medicine

  1. Important note:Do not add Ravicti to large volumes of liquid or mix it with these, as RAVICTI is heavier than most liquids. If you mix RAVICTI with large volumes of liquid, you may not get the full dose.
  2. RAVICTI can be added to a small amount of soft foods, such as ketchup, medical formulas, apple sauce, or pumpkin puree.
  3. If the volume of the oral syringe is less than the prescribed dose, you will need to repeat these steps to get the full dose. Use an oral syringe for all doses taken each day.
  4. After taking the full dose, drink a little water to make sure no medicine is left in the mouth, or flush the nasogastric or gastrostomy tube with 10 ml of water using a new oral syringe. The syringe used to flush the nasogastric or gastrostomy tube must not be used to measure the dose of RAVICTI, to avoid contact between water and the medicine.

Hand holding an auto-injector with a visible needle and a protector at the bottom

  1. Close the bottle by screwing the cap.

Hand holding an auto-injector with the thumb pressing the activation button and the other hand holding the device

  1. Important note:Do not rinse the oral syringe between daily doses, as adding water causes RAVICTI to degrade. If RAVICTI comes into contact with water, the liquid will appear cloudy. Keep the bottle and oral syringe in a clean and dry place between doses.
  2. Discard the oral syringe after the last dose of the day. Do not reuse the oral syringe to measure the dose of RAVICTI on another day.
  3. Unused syringes should be kept to use with another bottle. Each bottle must be discarded after 14 days.

If you take more RAVICTI than you should

If you take more of this medicine than you should, talk to your doctor.

If you notice any of the following symptoms, talk to a doctor or go to a hospital immediately, as they may be signs of overdose or high ammonia:

  • feeling sleepy, tired, or dizzy, sometimes confused
  • headache
  • changes in taste
  • hearing problems
  • feeling disoriented
  • reduced ability to remember things
  • existing neurological disorders may worsen.

If you forget to take RAVICTI

If you forget a dose, take it as soon as you remember. However, in adults, if the next dose is due in less than 2 hours, skip the missed dose and take the next dose at the usual time.

For children: if the next dose is due in less than 30 minutes, skip the missed dose and give the next dose at the usual time.

  • Do not take a double dose to make up for missed doses.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

If you stop taking RAVICTI

You will need to take this medicine and follow a special low-protein diet for the rest of your life. Do not stop taking RAVICTI without talking to your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience any side effects, talk to your doctor or pharmacist.

This medicine can cause the following side effects:

Common:may affect up to 1 in 10 people

  • swelling or stomach pain, constipation, diarrhea, stomach acid, gas, vomiting, feeling sick (nausea), mouth pain, retching
  • swelling of the hands or feet, feeling tired
  • feeling dizzy, headache, or shaking
  • decreased or increased appetite
  • aversion to certain foods
  • bleeding between menstrual periods
  • acne, unusual skin odor
  • blood test results showing increased liver enzymes, electrolyte imbalance, low white blood cell count (lymphocytes), or low vitamin D levels.

Uncommon:may affect up to 1 in 100 people

  • dry mouth
  • belching, stomach pain or discomfort, changes in stool, such as oily appearance, urgent need to defecate, painful defecation, inflammation of the mouth and lips
  • feeling hungry
  • increased temperature
  • hot flashes
  • gallbladder pain
  • bladder pain
  • back pain, joint pain, muscle spasms, pain in the arms or legs, heel spur syndrome
  • gastrointestinal viral infection
  • tingling sensation, feeling very restless, drowsiness, speech problems, feeling confused, feeling depressed, altered taste
  • cessation of menstruation or irregular menstrual periods
  • voice changes, nosebleeds, nasal congestion, or throat inflammation or pain
  • hair loss, increased sweating, itchy skin rash
  • irregular heartbeat
  • decreased thyroid function
  • weight loss or gain
  • blood test results showing increased or decreased potassium levels in the blood
  • blood test results showing increased levels of triglycerides, low-density lipoproteins, or white blood cells in the blood
  • abnormal electrocardiogram (ECG) results
  • increased prothrombin time in blood tests
  • blood test results showing decreased albumin levels in the blood

Side effects in children under 2 months

The following side effects have been observed in a clinical study with 16 patients under 2 months of age:

  • diarrhea, constipation, flatulence, reflux of stomach contents, insufficient feeding
  • rash
  • low red blood cell count
  • high platelet count (which can cause blood to clot)
  • increased liver enzymes
  • decreased amino acid levels

Side effects in children from 2 months to less than 2 years of age

  • diarrhea, constipation
  • eczema, nail striations, rash

Reporting side effects

If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this summary of product characteristics. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of RAVICTI

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton and bottle label, after EXP. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions. Once the bottle is opened, you must use this medicine within 14 days of opening. The bottle should be discarded even if it is not empty.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Packaging Contents and Additional Information

Composition ofRavicti

  • The active ingredient is glycerol phenylbutyrate.
  • Each milliliter of the liquid contains 1.1 g of glycerol phenylbutyrate. This corresponds to a density of 1.1 g/ml.
  • There are no other components.

Appearance of the Product andPackaging Contents

The liquid is contained in a 25 ml transparent glass bottle with a child-resistant plastic cap.

To ensure the correct administration of RAVICTI, oral syringes with CE marking, with a suitable size for the dose and compatible with the syringe insertion piece, can be obtained from the pharmacy. Ask your doctor or pharmacist what type of syringes you need, according to the prescribed dose volume.

Marketing Authorization Holderand Manufacturer

Marketing Authorization Holder

Immedica Pharma AB

SE-113 63 Stockholm

Sweden

Manufacturer

Unimedic AB

Storjordenvägen 2

SE-864 31 Matfors

Sweden

Date of the Last Revision of this Leaflet: 10/2022

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.

Online doctors for RAVICTI 1.1 G/ML ORAL LIQUID

Discuss questions about RAVICTI 1.1 G/ML ORAL LIQUID, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for RAVICTI 1.1 G/ML ORAL LIQUID?
RAVICTI 1.1 G/ML ORAL LIQUID requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RAVICTI 1.1 G/ML ORAL LIQUID?
The active ingredient in RAVICTI 1.1 G/ML ORAL LIQUID is glycerol phenylbutyrate. This information helps identify medicines with the same composition but different brand names.
Who manufactures RAVICTI 1.1 G/ML ORAL LIQUID?
RAVICTI 1.1 G/ML ORAL LIQUID is manufactured by Immedica Pharma Ab. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RAVICTI 1.1 G/ML ORAL LIQUID online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RAVICTI 1.1 G/ML ORAL LIQUID is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RAVICTI 1.1 G/ML ORAL LIQUID?
Other medicines with the same active substance (glycerol phenylbutyrate) include AMMONAPS 500 mg TABLETS, AMMONAPS 940 mg/g GRANULES, CERDELGA 84 mg HARD CAPSULES. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media